Gastrointestinal bleedings in cirrhosis;HEMORRAGIES DIGESTIVES DES CIRRHOSES

Revue du Praticien

Volumn 47, Issue 5, 1997, Pages 497-502

  Calés, Paul ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NADOLOL; PROPRANOLOL; SOMATOSTATIN; TERLIPRESSIN; VASOACTIVE AGENT; VASOPRESSIN;

CAUSE OF DEATH; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS; HUMAN; LIVER CIRRHOSIS; PRIMARY PREVENTION; SCLEROTHERAPY; SECONDARY PREVENTION; SHORT SURVEY; ARTICLE;

ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS;

EID: 0030809757     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (18)

1. Calés P, Pascal. Histoire naturelle des varices sophagiennes au cours de la cirrhose (de la naissance àla rupture). Gastroenterol Clin Biol 1988; 12:245-54.
2. Oberti F, Aube C, Casa C, Arnaud JP, Calés P. Méthodes de traitement des varices sophagiennes. Encycl Med Chir (Gastro-entérologie) I995;9-204-G-IO, 14p.
3. Bernard B, Valla D. Efficacité et mode d'action de la vasopressine dans le traitement des hémorragies digestives par rupture de varices sophagiennes ou gastriques. Gastroenterol Clin Biol 1994; 18:751-60.
4. Silvain C, Besson I, Beauchant M. Somatostatine, octréotide et hypertension portale. Gastroenterol Clin Biol 1994; 18: 761-6.
5. Combis JM, Vine) JP. Vasodilatateurs et hypertension portale. Gastroenterol Clin Biol 1991; 15:881-7.
6. Bernades P, Belghiti J, Bleichner G et al. Rapport de la réunion de consensus sur le traitement d'urgence des hémorragies digestives hautes de l'hypertension portale de la cirrhose. Gastroenterol Clin Biol 1990; 14: B 63-67.
7. Calés P, Oberti f. Stratégie du traitement hémostatique des hémorragies par rupture de varices sophagiennes. Gastroenterol Clin Biol 1995; 19: B I-B9.
8. De Franchis R, Pascal JP, Ancona E et al. Définitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 1992 ; 15:256-61.
9. De Franchis R. Portal hypertension II. Proceedings of the second Baveno International consensus workshop on definitions, methodology and therapeutic strategies. I'" ed. Oxford : Blackwell Science, 1996.
10. D'Amico G, Pagliaro L Bosch J. The treatment of portal hypertension : a meta-analytic review. Hepatology 1995 ; 22: 332-54.
11. Besson I, Ingrand P, Person P et al. Sclerotherapy with or without octréotide for acute variceal bleeding. N Engl J Med 1995; 333: 555-60.
12. Sung JJY, Sydney Chung SC et al. Prospective randomised study effect of octréotide on rebleeding from oesophageal varices after endoscopie ligation. Lancet 1995; 346: 1666-9.
13. Levacher S, Letoumelin P, Pateron D, Biaise M, Lapandry C, Pourriat JL Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346: 865-8.
14. Plevris JN, Elliot R, Mills PR et al. Effect of propranolol on prevention of first variceal bleed and survival in patients with chronic liver disease. Aliment Pharmacol Ther 1994 ; 8:63-70.
15. Groupe français de la prévention pré-primaire. Propranolol does not decrease the development of large esophageal varices in patients with cirrhosis. A controlled study. Hepatology 1995 ; 22 (4Pt2) : A155.
16. Calés P, Oberti F. Prévention de la rupture des varices sophagiennes. Encyl Med Chir I995;7-034-D-I5.
17. Merkel C, Gatta A, Marin R et al. Nadolol vs nadolol plus isosorbide-5-mono-nitrate for primary prophylaxis of variceal bleeding: a multicenter clinical trial. J Hepatol 1995; 23 (suppl l):69.
18. Villanueva C, Balanzo J, Novella MT et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal bleeding. N Engl J Med 1996; 25: 1624-9.